 1. Radiotherapy except for palliative reasons, endocrine therapy, immunotherapy or chemotherapy during the previous four weeks six weeks for nitrosoureas, Mitomycin-C and 4 weeks for investigational medicinal products before treatment, except for hormonal therapy with luteinizing hormone-releasing hormone analogues for medical castration in patients with CRPC, which are permitted. 